Company
Headquarters: Sydney, NSW, Australia
CEO: Dr. George Syrmalis M.D., Ph.D.
A$12.5 Million
AUD as of Feb. 1, 2022
US$8.9 Million
| Company | Market Cap (USD) |
|---|---|
| Morgan Stanley | $151.25 B |
| Goldman Sachs | $124.88 B |
| Schwab | $122.20 B |
| Macquarie Group Limited | $47.54 B |
| CITIC Securities Company Ltd | $40.07 B |
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $797.77 B |
| Visa | $530.20 B |
| JPMorgan | $495.55 B |
| Mastercard | $392.71 B |
| Bank of America | $267.48 B |
iQ3Corp Ltd provides capital raising and corporate advisory services to listed and unlisted companies in the life science industry in Australia. The company operates in two segments, Consulting Services, and Shared Services. It offers advisory services on initial public offerings, listings, private equity, mergers and acquisitions, structured finance, strategic matters, restructuring and capital structure, and corporate finance. The company also provides sell-side, buy-side, and NSX nominated advisory services. It serves corporations, partnerships, institutions, governments, and individuals. The company was incorporated in 2012 and is based in Sydney, Australia.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
iQ3Corp Ltd has the following listings and related stock indices.
Stock: ASX: IQ3 wb_incandescent